After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Dynavax Technologies Corp. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Dynavax Technologies Corp. is $1.67B. A total of 3.04 million shares were traded on the day, compared to an average of 1.84M shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, DVAX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 34 BUYs and 35 SELLs from insiders. Insiders purchased 375,468 shares during that period but sold 3,290,474.
In the most recent transaction, Janssen Robert sold 1,500 shares of DVAX for 15.00 per share on Jan 04. After the transaction, the SVP and CMO now owns 49,925 company shares. In a previous transaction on Jan 02, Novack David F sold 9,000 shares at 14.45 per share. DVAX shares that President & COO owns now total 3,187.
Among the insiders who sold shares, Novack David F disposed of 20,000 shares on Dec 01 at a per-share price of $13.56. This resulted in the President & COO holding 3,187 shares of DVAX after the transaction. In another insider transaction, Novack David F sold 20,000 shares at $15.00 per share on Nov 03. Company shares held by the President & COO now total 3,187.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for DVAX in the last 3 months, the mean price target is $25.40 with high estimates of $29.00 and low estimates of $20.00. In terms of 52-week highs and lows, DVAX has a high of $15.15 and a low of $9.42.
As of this writing, DVAX has an earnings estimate of $0.02 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of $0.06 per share and a lower estimate of -$0.02. The company reported an EPS of $0.1 in the last quarter, which was 1,100.00% higher than expectations of -$0.01.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DVAX’s latest balance sheet shows that the firm has $545.95M in Cash & Short Term Investments as of fiscal 2021. There were $257.38M in debt and $556.40M in liabilities at the time. Its Book Value Per Share was $4.68, while its Total Shareholder’s Equity was $222.37M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DVAX is Buy with a score of 4.60.
